in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/Fine Chemicals Roundup – 16 October
8:02 AM MDT | October 16, 2012 | Deepti Ramesh
Saltigo shuts US site Saltigo (Langenfeld, Germany), a Lanxess subsidiary, says it has discontinued production at the company’s Redmond, WA, site and that it has abandoned a previously announced plan to produce potent active pharmaceutical ingredients at that site. “We have decided to focus more on launched products or products in Phase III clinical trials and the Redmond site was involved in products required during phases I and II. So we have decided not to continue our activities in the US,” Wolfgang Schmitz, CEO of Saltigo, told CW...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee